Medicines, 2017
Shortlist up to four to read them side by side.
1,073 medicine recalls FDA’s Enforcement Report published in 2017, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,073of 1,073 medicine recallsshown with your filters
The list
- Medicine recall Oxytocin 10 units added to 500 mL Lactated Ringer’s Injection USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 15 units added to 250 mL Lactated Ringer’s Injection USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 20 units added to 1000 mL Lactated Ringer’s Injection USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 20 units added to 1000 mL Lactated Ringer’s Injection USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 20 units added to 1000 mL Lactated Ringer’s Injection USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 20 units added to 500 mL Lactated Ringer’s Injection USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 30 units added to 1000 mL 5% Dextrose/Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 30 units added to 500 mL 5% Dextrose/Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 30 units added to 500 mL Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 30 units added to 1000 mL Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 40 units added to 1000 mL Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 30 units added to 500 mL Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 40 units added to 1000 mL Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Oxytocin 40 units added to 1000 mL Lactated Ringer’s USP Subpotent Drug Class IIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Enalapril Maleate tablets, USP, 5mg, 1000-count bottles Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound. Class IIIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles Failed Dissolution Specifications: Low out of specification results for dissolution. Class IIIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 1, 2017ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound. Class IIIFDA’s classNov 1, 2017in FDA’s Enforcement ReportFloridathe one state its words name PublishedNov 1, 2017ClassClass IIIStatusTerminatedWhereFlorida
- Medicine recall Equate Beauty Clarifying Face Daily Moisturizer 4 fl Failed Stability Specifications Class IIIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Fluocinonide Gel USP, 0.05%, 15 g tube Cross contamination with other products: traces of Dapsone were found in the finished product. Class IIIFDA’s classNov 1, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 1, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Bisoprolol Fumarate tablets, 5 mg, 30-count bottles Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing. Class IIFDA’s classOct 25, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 25, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Symbio Muc Eye, 0.17 fl.oz. 5mL bottles Lack of Assurance of Sterility Class IIFDA’s classOct 25, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 25, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product. Class IIFDA’s classOct 25, 2017in FDA’s Enforcement Report6 statesnamed in where it went PublishedOct 25, 2017ClassClass IIStatusTerminatedWhereFlorida, Louisiana, Massachusetts, Ohio, Pennsylvania and Texas
- Medicine recall Alprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity. Class IIFDA’s classOct 25, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 25, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Mobic (meloxicam) tablets, 15 mg, package Labeling: Incorrect or missing package insert. Class IIIFDA’s classOct 18, 2017in FDA’s Enforcement Report2 statesnamed in where it went PublishedOct 18, 2017ClassClass IIIStatusTerminatedWhereColorado and Ohio
- Medicine recall Glutamine, Arginine and Carnitine, 10/100/200mg/mL, 30 mL (Multi Dose Vial) CGMP Deviations; FDA analysis deterrmined that the product does not contain glutamine and two unknown impurities were observed Class IIFDA’s classOct 18, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 18, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Famotidine tablets, 10 mg Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine… Class IIIFDA’s classOct 18, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 18, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial CGMP Deviations: Firm failed to control impurity for color change at the API stage. Class IIIFDA’s classOct 11, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 11, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Option Systems Antibacterial Foaming Hand Wash, 0.3% P.C.M.X., 8 fl oz and 18 fl oz GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump Class IIFDA’s classOct 11, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 11, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Mild Healthcare Antibacterial Hand Soap, 6% P.C.M.X., 1000 mL and 2000 mL Disc Pump, 800 mL Universal Valve,… GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump. Class IIFDA’s classOct 11, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 11, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Choice Antibacterial Hand Soap, (ethyl alcohol 61%) 800 ml/ 27 fl oz, Universal Valve, Inopak LTD, Ringwood,… GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump. Class IIFDA’s classOct 11, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 11, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Magnesium Citrate Oral Solution Lemon Flavor, 1.745g per fl oz Failed Impurities/Degradation Specifications. Class IIIFDA’s classOct 11, 2017in FDA’s Enforcement ReportNot namedno state, in where it went PublishedOct 11, 2017ClassClass IIIStatusTerminatedWhereNo state named
- Medicine recall Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz Failed Impurities/Degradation Specifications. Class IIIFDA’s classOct 11, 2017in FDA’s Enforcement ReportNot namedno state, in where it went PublishedOct 11, 2017ClassClass IIIStatusTerminatedWhereNo state named
- Medicine recall Ketorolac Trom 30 mg/mL Injection Crystallization: Product is being recalled due to the manufacturer’s recall due to the presence of visible particulate in vials that has been identified as… Class IIFDA’s classOct 4, 2017in FDA’s Enforcement ReportLouisianathe one state its words name PublishedOct 4, 2017ClassClass IIStatusTerminatedWhereLouisiana
- Medicine recall Sterile Water for Injection, USP Single Dose 100 mL vials Non-Sterility: cracked or chipped glass at the neck of Sterile Water for Injection vials. Class IIFDA’s classOct 4, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 4, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Acarbose Tablets, 25 mg, 100-count bottle Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct… Class IIFDA’s classOct 4, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 4, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels. Class IIIFDA’s classOct 4, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 4, 2017ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Quillivant XR methylphenidate HCl, for extended-release oral suspension, 600 mg/120 mL total volume (When… Failed Dissolution Specifications Class IIIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Quillivant XR methylphenidate HCl, for extended-release oral suspension, 750mg/150 mL total volume (When… Failed Dissolution Specifications Class IIIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Fentanyl Citrate (Preservative Free) 10 mcg per mL Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expiration date assigned to the compounded product. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Fentanyl Citrate (Preservative Free) 20 mcg per mL Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expiration date assigned to the compounded product. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Daytrana (methylphenidate transdermal system) Delivers 15 mg over 9 hours Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Procrit (epoetin alfa), 10,000 units/mL Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Aminocaproic Acid, USP CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use. Class IIFDA’s classSep 27, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 27, 2017ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.